DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20191688

Antifungal susceptibility testing for dermatophytes isolated from clinical samples by microbroth dilution method

Snehal Vilas Dhayagude

Abstract


Background: The cases of dermatophytoses have increased over the past few decades. Dermatophytoses affect the outer layers of skin, nails and hairs without tissue invasion. These infections are mostly not dangerous but, are important as public health problem particularly in the immunocompromised. The increased use of antifungal drugs for prolonged periods may lead to acquired antifungal resistance among previously susceptible strains. With this background present study was conducted to know the susceptibility pattern of dermatophytes.

Methods: A total 35 isolates of dermatophytes isolated from clinically suspected cases of dermatophytoses were examined. Broth microdilution method M38-A2 approved protocol of CLSI (2008) for filamentous fungi was followed for determining the susceptibility of dermatophyte species to antifungal agents- itraconaole, fluconazole and ketoconazole.

Results: Itraconazole minimum inhibitory concentrations (MIC) varied from 0.0156 to 1 µg/ml for all dermatophytes. T. rubrum species showed higher MIC range for Ketoconazole than T. mentagrophytes and T. tonsurans. Fluconazole had poor susceptibility for all dermatophytes by having higher MIC values.

Conclusions: The MIC values observed in present study will help clinician to select an appropriate antifungal agent with minimal side effects. The data from present study can be useful as reference for future studies covering large no. of isolates and more drugs.


Keywords


Antifungal susceptibility testing, Minimum inhibitory concentrations, T. rubrum, T. mentagrophytes, T. tonsurans

Full Text:

PDF

References


April M, Sowmya N, Appalaraju B, Cr S, Surendran P. Antifungal susceptibility testing for dermatophytes isolated from clinical samples by broth dilution method in a tertiary care hospital. JMR. 2015;1(2):64-7.

Balakumar, S., Rajan, S., Thirunalasundari T, Jeeva S. Epidemiology of dermatophytosis in and around Tiruchirapalli, Tamilnadu, India. Asian Pac J Trop Dis. 2012;2(4):286-9.

Bhatia VK, Sharma PC. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India. Springerplus. 2014;3(134):1-7.

Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8(2):240-59.

Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253-73.

Sharma S, Budhiraja RK, Bassi R. Current trends of antifungal susceptibility pattern of dermatomycosis in a tertiary care hospital by Etest and VITEK-2 methodologies. Indian J Clin Experiment Dermatol. 2018;4(2):90-5.

Adimi P, Jamal S, Mahmoudi M, Mirhendi H. In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran. Iran J Pharm Res. 2013;12(3):537-45.

Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi ; Approved Standard – 2nd ed. Available at: https://clsi.org/media/1455/m38a2_sample.pdf.

Bhatia VK, Sharma PC. Determination of minimum inhibitory concentrations of itraconazole,terbinafine and ketoconazole against dermatophyte species by broth microdilution method. Indian J Med Microbiol. 2015;33(4):533-7.

Altinbaş R, Özakkaş F, Bariş A, Turan D, Şen S. In vitro susceptibility of seven antifungal agents against dermatophytes isolated in İstanbul. Turkish J Med Sci. 2018;48(3):615-9.

Korting HC, Ollert M, Abeck D, German THE. Results of German Multicenter Study of Antimicrobial Susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes Strains Causing Tinea Unguium. 1995;39(5):1206-8.

Pakshir K, Bahaedinie L, Rezaei Z, Sodaifi M, Zomorodian K. In vitro activity of six antifungal drugs against clinically important dermatophytes. Jundishapur J Microbiol. 2009;2(4):158.

Gadangi I. Clinical Microbiology : Open Access In Vitro Antifungal Susceptibility Testing of 5 Antifungal Agents against Dermatophytic Species by CLSI (M38-A) Micro Dilution Method. Clin Microb. 2014;3(3):1-5.